Author: Site Editor Publish Time: 09-15-2026 Origin: Site
For clinics and spas involved in hair loss management, two terms are hard to avoid: PRP and exosomes. When it comes to exosome vs PRP for hair, both are regenerative approaches, but their sources, mechanisms, and level of standardization are quite different. Distributors and doctors are often asked, “Which one is better?” There is no single answer. It depends on the type of hair loss, follicle condition, clinic workflow, and the patient’s comfort with blood collection.
Hair loss can have different causes, including androgenetic alopecia (AGA), telogen effluvium, alopecia areata, scarring alopecia, traction alopecia, and some nutritional or treatment-related conditions.
For regenerative hair treatments, one key question is whether the follicle is still viable. If a follicle has been permanently destroyed by scarring, PRP or exosomes cannot restore it. Hair transplantation or treatment of the underlying condition may need to be considered instead.
Diagnosis should come before treatment selection.
Exosomes are nanoscale extracellular vesicles released by cells. They can carry signaling molecules such as proteins, growth factors, mRNA, and miRNA. Exosomes are not cells themselves but are involved in cell-to-cell communication.
In hair regeneration, exosome-based treatments aim to support follicle activity and the local scalp environment through these signaling molecules. They do not directly “grow” hair.
PRP (platelet-rich plasma) is prepared from the patient’s own blood. Blood is collected and processed to obtain plasma with a high concentration of platelets, which is then injected into the scalp.
PRP has a longer history of clinical research in hair restoration, particularly for androgenetic alopecia. It contains platelet-derived growth factors and other signaling proteins that may support the local scalp environment and hair growth.
Factor | Exosomes | PRP |
Source | Various sources, such as donor-derived mesenchymal stem cells | Patient’s own blood |
Main components | Extracellular vesicles and targeted signaling molecules | Platelets and various growth factors |
Standardization | Relatively high, depending on the product and manufacturing process | More affected by patient variability and operator technique |
Treatment workflow | Ready-to-use finished product | Blood collection + centrifugation + injection |
Research background | Newer field; clinical evidence is still developing | Longer history of clinical research, especially for AGA |
There is currently no conclusive evidence that one treatment is generally better than the other.
PRP has a longer history of use and research in hair loss treatment, but its results can be affected by blood processing, platelet preparation, injection technique, and treatment protocol.
Exosome-based treatments are newer. They do not contain intact cells and are generally considered to have low immunogenicity. Their finished-product format can also support greater standardization, although batch consistency still depends on the manufacturing process. Current studies are smaller, and long-term research is still developing.
Neither treatment is a “one-time” solution for hair loss. The choice should be based on the patient’s hair loss type, follicle condition, and treatment goals.
In practice, the choice often comes down to three questions: Is the follicle still viable? Does the patient accept blood collection? Can the clinic support the required workflow?
More suitable for PRP:
Patients with AGA who prefer a treatment with a longer clinical research history
Patients who are comfortable with blood collection
Clinics that already have trained staff and centrifugation equipment
Clinics that want to add PRP to an existing hair restoration workflow
More suitable for exosomes:
Patients who prefer to avoid blood collection
Clinics looking for a finished-product treatment workflow
Clinics or distributors evaluating standardized, ready-to-use product options
Selected cases where regenerative or cell-signaling approaches are being considered as part of a broader hair management plan
Cases that may need other treatment first:
Scarring alopecia with destroyed follicles
Active alopecia areata requiring appropriate disease management
Hair loss caused by an underlying condition that has not yet been addressed
The two can be considered for combined use, but the combination treatment plan needs to be carefully designed.
A common approach is to use PRP as a base and add exosomes. Another option is to use them separately—for example, PRP every 4–6 weeks, with exosomes added during the maintenance phase.
The logic behind the combination is that their mechanisms may complement each other: PRP provides a “boost” of platelet-derived growth factors, while exosomes provide more sustained cell-to-cell signaling support. However, several points should be considered:
Check product compatibility before mixing. Not all exosome products are suitable for direct mixing with PRP.
Costs will increase. Pricing and treatment plans should be calculated in advance.
ombination treatment is not necessary for everyone. For mild to moderate AGA, using either treatment alone may be sufficient.
PRP and exosomes are not simply competing products. They are two different tools for non-surgical hair management.
If you are evaluating an exosome hair treatment for your product line, contact us for product specifications, sourcing, and cooperation options.
